Skip to main content
Clinical Orthopaedics and Related Research logoLink to Clinical Orthopaedics and Related Research
. 2019 Aug 22;478(3):504–505. doi: 10.1097/CORR.0000000000000933

CORR Insights®: Are Accelerometer-based Functional Outcome Assessments Feasible and Valid After Treatment for Lower Extremity Sarcomas?

Joel L Mayerson 1,
PMCID: PMC7145063  PMID: 31453889

Where Are We Now?

Physicians often use performance-based clinical assessments like physical therapist evaluations or standardized scoring systems to assess function in our patients. Modern technology is impacting health care in many ways, but little is known about how we might use wearable technology to devise new clinical assessments of function for patients with sarcoma.

Traditional functional outcome measures in sarcoma care include the Musculoskeletal Tumor Society Functional Assessment Score [3] and the Toronto Extremity Salvage Score [2]. Generally, gait has been studied in a laboratory using force plates that include costly equipment not easily used by the general public [1]. But recently, we have seen tremendous growth in personal wearable technology, including a number of devices that give users a somewhat-accurate assessment of the distance, time, places, and types of activities that we participate in. Other wearable devices can measure heart rate, the number of steps we take, and the number of stairs we climb. It seems reasonable, therefore, for clinician-scientists to explore the breadth of disease processes that can be analyzed with wearable technology [5, 7].

In the current study, Furtado and colleagues [4] bring wearable technology into the clinical realm of sarcoma care. To my knowledge, they are the first to report accelerometer-based body-worn monitor assessments of balance, gait, and timed up-and-go tests to produce clinically useful data. Furtado and colleagues [4] demonstrate in a small subset of patients that wearable devices can be used to discriminate balance and gait differences between controls and limb salvage patients.

Where Do We Need To Go?

As physicians, we know that sometimes our patients travel long distances to receive care, which imposes burdens of cost, time, and stress on patients and their families. Therefore, we should not be surprised that when patients perceive they have recovered to a reasonable level, they may opt not to return, even when the surgeon would like additional in-person follow-up. Future studies should examine whether video technology as a part of surgical aftercare is a viable and affordable option for patients with sarcomas. Can wearable devices safely and privately transmit valuable real-time data to a physical therapist, for example, who then can both analyze a patient’s progress and guide his or her next steps in care? Can new models of care combining technology led by wearable devices improve patient satisfaction? Will the healthcare system support the implementation of such approaches? If wearable sensors are reliable, we can then confidently recommend their use for physical therapy and rehabilitation following limb salvage surgery. This technology is only gaining in popularity, and so physicians should embrace telemedicine for follow-up appointments, as patients will likely demand them anyway. Should these approaches be validated by robust clinical research, insurers then will need to adopt payment mechanisms that incent patients to purchase wearable technology, and physicians to employ technology to receive results from these devices, and to provide remote care facilitated by these devices.

How Do We Get There?

Collaborative research between physical therapists, engineers, and surgeons at high-volume sarcoma centers will be needed to lead the way in demonstrating that these devices capture the appropriate data to direct outcomes directed care for each type of limb salvage procedure. Once researchers document the utility of wearable technology, we must begin to change care teams and how they function. Physical therapists will need to be more closely integrated in the follow-up care of patients who underwent limb salvage surgery. The therapist should be able to use the data from wearable technology, discuss it with the physician, and provide care progression. This transition in care will be challenging for the healthcare system, but will become easier as bundled care encourages further integration within systems.

In my region, the patients who are most in need of receiving care closer to home lack the financial resources to gain access to the technology that can provide them with local care. But physical therapists may no longer need an individual gym in a facility. Instead, they may direct their patients to perform activities that do not require expensive equipment, or to utilize wearable technology so the therapist can monitor their progress via internet-driven video platforms. Recovery from major limb salvage surgery can range between months to even years. New paradigms that utilize wearable technology to decrease the number of physician and physical therapy visits will decrease cost. Once insurers realize these devices decrease costs, they will facilitate improved integration of care by providing wearable technology for their constituents. The cost savings will allow those with the least financial resources to gain access to local or specialty care that is otherwise not currently obtainable.

Footnotes

This CORR Insights® is a commentary on the article “Are Accelerometer-based Functional Outcome Assessments Feasible and Valid After Treatment for Lower Extremity Sarcomas?” by Furtado and colleagues available at: DOI: 10.1097/CORR.0000000000000883.

The author (JLM) receives research support from DePuy Synthes and Onkos Surgical.

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.

The opinions expressed are those of the writer, and do not reflect the opinion or policy of CORR® or The Association of Bone and Joint Surgeons®.

References

  • 1.Baker R, Esquenazi A, Benedetti MG, Desloovere K. Gait Analysis: Clinical facts. Eur J Phys Rehabil Med. 2016;52:560-574. [PubMed] [Google Scholar]
  • 2.Davis AM, Wright JG, Williams JI, Bombardier C, Griffin A, Bell RS. Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res. 1996;5:508–516. [DOI] [PubMed] [Google Scholar]
  • 3.Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241–246. [PubMed] [Google Scholar]
  • 4.Furtado S, Godfrey A, Del Din S, Rochester L, Gerrand C. Are accelerometer-based functional outcome assessments feasible and valid after treatment for lower extremity sarcomas? Clin Orthop Relat Res. [Published online ahead of print]. DOI: 10.1097/CORR.0000000000000883. [DOI] [PMC free article] [PubMed]
  • 5.Gordt K, Gerhardy T, Najafi B, Schwenk M. Effects of wearable sensor-based balance and gait training on balance, gait, and functional performance in healthy and patient populations: A systematic review and meta-analysis of randomized controlled trials. Gerontology. 2018;64:74-89. [DOI] [PubMed] [Google Scholar]
  • 6.Lang RL, Wilson C, Stockton K, Russell T, Johnston LM. CyFiT telehealth: Protocol for a randomised controlled trial of an online outpatient physiotherapy service for children with cystic fibrosis. BMC Pulm Med. 2019;19:21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Vienne-Jumeau A, Quijoux F, Vidal PP, Ricard D. Value of gait analysis for measuring disease severity using inertial sensors in patients with multiple sclerosis: protocol for a systematic review and meta-analysis. Syst Rev. 2019;8:15. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Orthopaedics and Related Research are provided here courtesy of The Association of Bone and Joint Surgeons

RESOURCES